Greece Gastrointestinal Drug Industry Outlook 2022 - 2026

See how Greece Gastrointestinal Drug performed compared to key markets such as South Korea, Italy and Germany.

Key Market Indicators

Greek antacid medicine sales are projected to hit $6.3 million by 2026. In 2021, the Greek market was worth $6.7 million, showing a slight decrease of less than one percent each year on average. Since 2003, the industry has seen an average annual growth of 7 percent. In 2021, the country ranked ninth in the world. Portugal was in the lead with $6.7 million, followed by Italy, Germany and Chile.

Greece Gastrointestinal Drug Market Data and Forecasts

How much will Greece Gastrointestinal Drug Market grow to 2026?

Forecast: Antacid Medicine Sales in Greece
Forecast: Antacid Medicine Sales in Greece
Forecast: Antacid Medicine Sales in Greece
Forecast: Antacid Medicine Sales in Greece
Forecast: Antacid Medicine Sales in Greece

Other Top Countries about Gastrointestinal Drug